bioTheranostics, Inc., a leader in molecular diagnostics for cancer, today announced the addition of two industry veterans to its senior management team as the company focuses on further commercial expansion of its Breast Cancer IndexSM (BCI) molecular test. Jennifer Skeen, Ph.D., joins bioTheranostics as Vice President of Clinical Operations, and Sue Beruti, M.D., joins as Medical Director.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
